Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy-Reference-Cited by-同舟云学术

Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy

Published:2012-03-05 Issue:7 Volume:53 Page:1321-1326
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Tantiworawit Adisak,Power Maryse M.,Barnett Michael J.,Hogge Donna E.,Nantel Stephen H.,Nevill Thomas J.,Shepherd John D.,Song Kevin W.,Sutherland Heather J.,Toze Cynthia L.,Abou-Mourad Yasser R.,Narayanan Sujaatha,Broady Raewyn C.,Forrest Donna L.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.652108

Reference21 articles.

1. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

2. Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate

3. Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy

4. Sudden onset of the blastic phase of chronic myelogenous leukemia

5. Sudden Extramedullary T-Lymphoblastic Blast Crisis in Chronic Myelogenous Leukemia

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia;International Journal of Molecular Sciences;2024-03-14

2. Treatment discontinuation in chronic myeloid leukemia: When, how, and why?;American Journal of Hematology;2023-09-27

3. Risk of progression in chronic phase‐chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR‐PRO study;American Journal of Hematology;2023-08-30

4. Sudden extramedullary and extranodal Philadelphia-positive anaplastic large-cell lymphoma transformation during imatinib treatment for CML: A case report;World Journal of Clinical Cases;2022-10-06

5. Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success;American Journal of Hematology;2022-04-12